TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 101 filers reported holding TG THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $241,000 | -7.3% | 5,000 | 0.0% | 0.02% | -13.8% |
| Q4 2020 | $260,000 | +33.3% | 5,000 | -50.0% | 0.03% | +7.4% |
| Q2 2020 | $195,000 | +99.0% | 10,000 | 0.0% | 0.03% | +92.9% |
| Q1 2020 | $98,000 | -65.1% | 10,000 | -80.0% | 0.01% | -53.3% |
| Q3 2019 | $281,000 | -35.1% | 50,000 | 0.0% | 0.03% | -36.2% |
| Q2 2019 | $433,000 | +7.7% | 50,000 | 0.0% | 0.05% | +11.9% |
| Q1 2019 | $402,000 | +96.1% | 50,000 | 0.0% | 0.04% | +82.6% |
| Q4 2018 | $205,000 | -77.1% | 50,000 | -68.8% | 0.02% | -74.7% |
| Q3 2018 | $896,000 | -57.4% | 160,000 | 0.0% | 0.09% | -60.8% |
| Q2 2018 | $2,104,000 | -7.4% | 160,000 | 0.0% | 0.23% | -13.1% |
| Q1 2018 | $2,272,000 | +73.2% | 160,000 | 0.0% | 0.27% | +72.3% |
| Q4 2017 | $1,312,000 | -30.8% | 160,000 | 0.0% | 0.16% | -36.7% |
| Q3 2017 | $1,896,000 | +214.4% | 160,000 | +166.7% | 0.24% | +202.5% |
| Q2 2017 | $603,000 | -13.7% | 60,000 | 0.0% | 0.08% | -18.2% |
| Q1 2017 | $699,000 | – | 60,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,198,337 | $33,613,000 | 1.96% |
| GREAT POINT PARTNERS LLC | 3,000,000 | $12,300,000 | 1.56% |
| BRIDGER MANAGEMENT, LLC | 3,791,531 | $15,545,000 | 1.30% |
| Avoro Capital Advisors LLC | 4,750,000 | $19,475,000 | 1.16% |
| Opaleye Management Inc. | 550,000 | $2,255,000 | 0.84% |
| CREDIT AGRICOLE S A | 1,307,428 | $5,360,000 | 0.30% |
| Eversept Partners, LP | 65,000 | $266,500 | 0.14% |
| HIGHLAND CAPITAL MANAGEMENT LP | 453,360 | $1,859,000 | 0.14% |
| 683 Capital Management, LLC | 500,000 | $2,050,000 | 0.12% |
| Artal Group S.A. | 400,000 | $1,640,000 | 0.06% |